BioCentury
ARTICLE | Financial News

Repligen raises $100M in debt deal

May 20, 2016 12:21 AM UTC

Bioprocessing company Repligen Corp. (NASDAQ:RGEN) raised $100 million in a senior convertible notes offering. The notes bear 2.125% interest, mature on June 1, 2021, and initially convert at $32.07, a 22% premium to the company's Wednesday close of $26.18 before the deal was announced. ...